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Salmon lice Lepeophtheirus salmonis (Krøyer, 1837)
are small marine ectoparasites that feed on mucous,
blood and skin of Atlantic salmon Salmo salar and
sea trout Salmo trutta. If present in sufficient num-
bers, salmon lice may cause large-scale mortalities
as a result of osmotic stress and secondary infections
caused by bacterial and viral pathogens (Burka et
al. 2012). Salmon lice infestations are therefore con-
sidered a major problem for the Atlantic salmon
aquaculture industry in Europe and North America
(Costello 2006, 2009, Burka et al. 2012). In addition to
reducing the general welfare of the farmed fish,
salmon lice cause significant economic loss due to
reduced growth, increased mortality, downgrading
of flesh quality and the cost of delousing treatments
(MacKinnon 1997). Furthermore, excessive numbers
of adult lice in the vicinity of salmon farms increase
the number of free-swimming larvae in the sur-
rounding waters and consequently have a negative
impact on wild populations of sea trout and migrating
wild post-smolts of Atlantic salmon (Wagner et al.
2008, Costello 2009, Skaala et al. 2014).
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ABSTRACT: Anti-parasitic drugs used to control sea lice infestations in the salmonid aquaculture
industry are a growing environmental concern due to their potential impacts on non-target crus-
tacean species. This study examined the lethal effects of teflubenzuron, a common in-feed phar-
maceutical drug used on Norwegian salmon farms, on a non-target species, rockpool shrimp
Palaemon elegans, following an extended exposure period. The standard daily dose for treating
salmon is 10 µg teflubenzuron g−1 fish. Adult shrimp were fed 1 of 6 low doses of teflubenzuron (0,
0.0025, 0.005, 0.05, 0.094, 0.188 and 1.88 µg g−1) twice a week for a period of 66 d. Cumulative
mortality reached 15, 27, 82 and 100% amongst shrimp exposed to the highest treatment groups
(0.05, 0.094, 0.188 and 1.88 µg g−1, respectively). Cumulative mortality amongst shrimp exposed to
the 2 lowest teflubenzuron doses and control feed was low (5%). Dose response curves based on
measured concentrations within the shrimp were used to calculate a series of lethal threshold con-
centrations (LCx). The LC5, LC50 and LC90 concentrations of teflubenzuron causing low, median
and high levels of mortality in rockpool shrimp were estimated to be 1.2, 18.4 and 150.6 ng g−1,
respectively. These concentrations are similar to those reported in wild crustacean species, includ-
ing shrimp species in the vicinity of Norwegian fish farms, both during and after teflubenzuron
medication, suggesting that exposure to low doses of this compound can pose a significant risk to
wild shrimp populations.
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Several anti-parasitic agents are currently in use
for delousing farmed fish; these compounds are
either dissolved in water and used in bath treatments
or administered orally via the feed. The in-feed drugs
used in Norway are the flubenzurons (teflubenzuron,
diflubenzuron) and emamectin-benzoate. Fluben-
zurons act by interfering with the synthesis of chitin
in the salmon lice and are effective against all stages
of lice that undergo moulting, including the larval
and pre-adult stages (Branson et al. 2000, Ritchie et
al. 2002, Campbell et al. 2006). Teflubenzuron is
administered via medicated pellets containing 2 g
active compound per kg feed, and the recommended
dosing regime is 10 mg kg–1 fish, daily for 7 d. The
bioavailability of teflubenzuron in Atlantic salmon is
low (~10%), the metabolism minimal, and the elimi-
nation pathway is via liver and bile to the intestine
(Anon 1999). Therefore, most of the drug is released
from the fish as the parent compound during medica-
tion and shortly after treatment (Anon 1999). Solubil-
ity of teflubenzuron in water is low (0.0094 mg l–1
at 20°C), and the substance associates readily with
particles rich in organic content (Marsella et al. 2000).
It is, therefore, reasonable to suggest that tefluben-
zuron enters the environment bound to excess feed
and faecal particles. Indeed, a preliminary study ana -
lysing faecal material from Atlantic salmon undergo-
ing medication with teflu benzuron showed concen-
trations more than twice the initial concentration in
the medicated feed (O. B. Samuelsen unpubl. data).
Teflubenzuron residues have been detected in sev-
eral species of wild fauna in the vicinity of fish farms,
including polychaete worms, crustaceans and fish
(Langford et al. 2014, Samuelsen et al. 2015), and in
species inhabiting the intertidal zone, such as the
amphipod Gammarus locusta and the blue mussel
Mytilus edulis (Langford et al. 2014). Consequently,
there is growing concern about the potential impacts
of teflubenzuron exposure on non-target marine
crustaceans. The acute toxicity of teflubenzuron has
previously been examined in both marine and terres-
trial arthropods (Coppen & Jepson 1996 a,b, Koy-
anagi et al. 1998, Abo-Elghar et al. 2004, Medeiros et
al. 2013). Indeed, in our previous work, both lethal
and non-lethal effects of teflubenzuron on juvenile
European lobster Homarus gammarus were ob -
served following oral administration of the drug (10
and 20 mg kg–1 lobster) for 7 d (Samuelsen et al.
2014). In two similar studies, oral administration of
diflubenzuron (600 mg kg–1 feed) also caused lethal
effects in larvae and adult deepwater shrimp Pan-
dalus borealis following intermittent dosing for 14 d
(Bechmann et al. 2017, 2018). In these studies, the
medication periods were short and diflubenzuron
doses were high. Since the half-life of teflubenzuron
in marine sediment was estimated to range between
115 and 170 d (Langford et al. 2014, Samuelsen et al.
2015), low doses of teflubenzuron are likely to be
available for an ex tended period. Indeed, low con-
centrations of teflu benzuron were detected in deep-
water shrimp and Norway lobster Nephros nor -
wegicus collected in the vicinity of a Norwegian
salmon farm 8 mo post-treatment with teflubenzuron
(Samuel sen et al. 2015). To date there is limited infor-
mation available on the toxicity of low doses of
teflubenzuron to marine crustaceans following long-
term exposure.
The aim of this study was to examine the lethal
effect of orally administered teflubenzuron on adult
rockpool shrimp Palaemon elegans offered low doses
of the drug over an extended period. To do this,
shrimp were fed teflubenzuron-medicated feed twice
a week for 66 d, the proportion of dead shrimp was
recorded to produce a dose-response curve, and a
series of lethal threshold concentrations (LCx) were
estimated. Rockpool shrimp are a common species
found along the coast of the western Atlantic, from
Scotland and Norway to Mauritania, as well as the
entire Mediterranean Sea and the Black Sea (Reu -
schel et al. 2010). They are typically found in rock-
pools or sandy bottoms covered with algae and eel-
grass in the tidal zone. In Norway, rockpool shrimp
are common in marine areas with aquaculture facili-
ties and therefore are likely to be exposed to chemi-
cal agents used for salmon delousing.
2.  MATERIALS AND METHODS
2.1.  Animal collection and maintenance
Adult rockpool shrimp were captured in a large
basin at the Institute of Marine Research (IMR) field
station at Parisvatnet, outside Bergen, Norway. The
distance from the field station to the nearest commer-
cial salmon farm is ca. 6 km. The captured shrimp
were transferred to the IMR facility in Bergen and
initially placed indoors in 2 m3 tanks supplied with
ambient seawater (13°C) at a flow rate of ~10 l min−1.
Prior to the experiment, shrimp were moved into
individual 171 cm3 white PVC plastic compartments
(7.0 × 3.5 × 7.0 cm) and randomly divided into 7
groups of 60 to 80 individuals. Each group was
placed in a  separate 2 m3 tank, supplied with ambi-
ent seawater under the same conditions (13°C, flow
rate 10 l min−1). The individual compartments had
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perforated floors (2.5 mm in diameter) to ensure
adequate water flow. The shrimp were fed commer-
cially produced 2 mm marine pellets (Skretting,
Norway) and natural feed such as blue mussel
Mytilus edulis. The shrimp were allowed to acclima-
tise and adapt to pelleted feed for 3 wk prior to the
initiation of medi cation. The mean shrimp total length
(n = 60) was 40.8 ± 13.9 mm and mean shrimp weight
was 0.80 ± 0.30 g.
2.2.  Teflubenzuron exposure
Following acclimatisation, teflubenzuron-medicated
feed was orally administered to the shrimp at 1 of 6
dose levels (0, 0.0025, 0.005, 0.05, 0.094, 0.188 and
1.88 µg g–1 shrimp) in order to generate cumu lative
mortality curves. The dose range was selected to
encompass concentrations causing 0 and 100%
mortality, based on preliminary experiments (O. B.
Samuelsen unpubl. data). The highest dose corre-
sponded to 18.75% of the daily dose given to Atlantic
salmon during medication (10 µg g–1). Six groups,
each containing 60 shrimp, were given medicated
feed, and 1 group, containing 80 shrimp, was given
non-medicated feed. Each treatment group was
assigned to separate water tanks (2 m3) supplied with
running seawater (10 l min–1) at a temperature of
13°C. Each shrimp was fed 1 pellet (mean ± SD
weight = 24.4 ± 2.1 mg) twice a week for 66 d. The
medicated feeds were customised to a 0.80 g individ-
ual and made by homogeneously mixing the appro-
priate amount of teflubenzuron with 1 g glucose.
Using a few drops of herring oil and gentle shaking,
the drug was coated on batches of 50 g pellets.
Mortality was monitored daily, and dead shrimp
were removed and stored at −18°C for further analy-
sis. After 66 d, the study was terminated, and a subset
of individuals from each group was frozen and kept at
−18°C for further analysis. LCx values were calculated
based on mortality after 66 d of teflubenzuron medi -
cation and were determined and reported based on
measured teflubenzuron concentrations in the shrimp.
2.3.  Teflubenzuron residues: chromatographic
analysis
Accumulation of teflubenzuron in whole shrimp
was determined in 10 to 15 shrimp per dosing group
and 28 shrimp in the control group.
The preparation of solutions and samples was per-
formed as described by Olsvik et al. (2015), with
some modifications. Briefly, whole shrimp were ho -
mogenized using a whirl mixer and teflubenzuron
was extracted from the homogenate using acetone.
Diflubenzuron-d4 was used as internal standard and
added to the homogenate prior to extraction. As
rockpool shrimp are low in lipid content, the analyti-
cal step of removing fat using heptane, described in
Olsvik et al. (2015), was not included here. The ex -
tracts were purified using an automated solid phase
extraction technique (ASPEC). Quantification was per-
formed using an Agilent 1290 LC-system (Agilent
Technologies) coupled with an Agilent 6460 triple
quadrupole mass spectrometer (Agilent Technologies).
The instrument was equipped with an electrospray
ionization (ESI) source operated in a negative mode.
The analytes were separated by a reverse phase Agi-
lent stable bond C18-column (150 mm × 2.1 mm i.d.
1.8 µm particle size) (Agilent Technologies) using a
0.4 ml min−1 flow. The mobile phase was a mixture of
acetonitrile and water. Chromatography was per-
formed using a stepwise gradient: 0−0.2 min, 20%
acetonitrile; 3.0 min, 98% acetonitrile; 3.1–5.0 min,
20% acetonitrile. All gradient steps were linear. The
retention time for teflubenzuron and diflubenzuron-
d4 were 2.94 and 2.53 min, respectively. The analyte
and internal standard were detected in the multiple
reaction monitoring mode (MRM). The mass to charge
(m/z) ratios used were previously described in Olsvik
et al. (2015). The following ion source parameters
were used: sheat gas temperature: 310°C; sheat gas
flow: 11 l min−1; nebulizer pressure: 45 psig; drying
gas temperature: 320°C; drying gas flow: 10 l min−1;
capillary voltage: 3500 V; nozzle voltage: 500 V. Pro-
cedural blank, matrix blank, matrix-matched cali -
bration curve and controls were prepared for each
series. The limit of quantification (LOQ) was deter-
mined to 1.0 ng g−1 and the method was linear (r =
0.99) over the range studied (1−1500 ng g−1).
2.4.  Statistical analysis
All statistical analyses were conducted in R (R Stu-
dio, 3.4.3) (RStudio Team 2016). LCx values and their
95% confidence intervals (CI) were calculated using
generalised linear models (GLMs) with binomial
error structures and probit links according to Finney
(1971). Residual teflubenzuron concentrations were
log transformed (log10) to linearise the data. Data was
plotted using the ggplot2 R package (Wickham 2009).
The differences between intermolt periods was as-
sessed using a GLM with a Gaussian error structure
and inverse link.
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3.  RESULTS
3.1.  Measured teflubenzuron concentrations
Following oral administration of teflubenzuron, the
mean residue concentrations of teflubenzuron in the
shrimps increased successively from 2.0 ng g–1 wet
weight (ww) for the lowest dose to 568.4 ng g–1 (ww)
for the highest dose (Table 1). The mean teflu -
benzuron concentration in control shrimp was 0.3 ±
0.2 ng g−1 ww. While the measured concentrations
were below the limit of detection (<1 ng g−1) in 25 of
28 control shrimp analysed, low concentrations of
teflubenzuron (1.1, 2.7 and 3.8 ng g−1 ww) were de -
tected in 3 individuals.
3.2.  Mortality
For the 2 lowest doses of teflubenzuron, mortality
was as low as in the control group (5%, Table 1).
How ever, mortality increased with increasing doses,
reaching 100% in the high-dosed group (Table 1).
Mean (± SE) cumulative mortality amongst shrimp
fed control feed was 5.0 ± 2.5%. The mortality in the
groups exposed to the 4 highest doses started be -
tween Day 6 and 9 after first feeding. A series of
lethal threshold concentrations were estimated based
on a dose- response curve with shrimp mortalities and
mean measured teflubenzuron concentrations (Fig. 1,
Table 2).
Most of the mortality in the high-dosed groups
could be related to first moult. Of the rockpool
shrimp exposed to teflubenzuron concentrations
lower than 0.094 ug g–1, between 60 and 90% were
observed to have moulted at least once, and 70
individuals were noted to have moulted twice. In
these 70 individuals, the intermoult period was 25.1 ±
5.7 d. There was no significant difference in the
intermoult periods between treatment groups (GLM,
F3,54 = 3.9e+05, p = 0.38).
4.  DISCUSSION
In this investigation, rockpool shrimp were orally
administered low doses of teflubenzuron for an
extended period in order to mimic a field situation
where non-target organisms are exposed to low con-
centrations of the drug for several months following
deployment in nearby aquacultural facilities (Lang-
ford et al. 2011, Samuelsen et al. 2014). We show that
teflubenzuron induced significant mortality amongst
rockpool shrimp following a 66 d exposure, with
an estimated LC5, LC50 and LC90 of 1.2, 18.4 and
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Administered Measured concen- Mortality
dose (µg g−1) tration (ng g−1 ww) (%)
0 0.3 ± 0.2 5.0 ± 2.5
0.0025 2.0 ± 0.6 5.0 ± 2.8
0.005 1.5 ± 0.5 5.0 ± 2.8
0.05 7.3 ± 1.8 15.0 ± 4.7
0.094 14.9 ± 3.5 26.7 ± 5.8
0.188 27.4 ± 5.7 81.7 ± 5.0
1.88 568.4 ± 142.2 100.0 ± 0.0
Table 1. Mortality and measured teflubenzuron concentra-
tions (mean ± SE) in rockpool shrimp following a 66 d oral 
administration period. ww: wet weight






















Table 2. Estimated lethal threshold concentrations (with cor-
responding 95% confidence intervals) of teflubenzuron for
rockpool shrimp based on mean measured concentrations in
shrimp following a 66 d oral administration period
Fig. 1. Toxicity of teflubenzuron to adult rockpool shrimp
following a 66 d oral administration period. Dose-response
curve shows mean fractional mortality of shrimp against
mean measured concentrations of teflubenzuron and the
line represents the best fit model for the data, calculated
using a binomial log-probit GLM in R
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150.6 ng g−1 ww shrimp based on measured internal
concentrations. To our knowledge, no lethal thresh-
old concentrations for teflubenzuron have been cal-
culated for marine crustaceans following oral admin-
istration to date, therefore, direct comparison of our
results with previous studies is not possible. A recent
study by Olsvik et al. (2017), however, did examine
mortality of rockpool shrimp following a 98 d expo-
sure to a single low dose of teflubenzuron via diet. In
that study, the mean measured concentration of
teflubenzuron amongst ex posed shrimp was 10 ng g−1
ww shrimp and cumulative mortality reached 50%
by the end of the exposure period (Olsvik et al. 2017).
This is in line with the results observed in the present
study, where cumulative mortality reached 40%
amongst shrimp with the same internal concentration
of teflubenzuron (i.e. 10 ng g–1 ww shrimp), albeit
after a shorter exposure period (66 d). Interestingly,
pink shrimp Pandalus montagui orally exposed to
low or high doses of teflubenzuron for 46 d at a water
temperature of 9°C appear to be slightly less sensi-
tive than the rockpool shrimp examined here. Cumu-
lative mortality amongst exposed pink shrimp was
relatively low (25 and 0%, respectively) in groups
with mean measured concentrations of tefluben-
zuron that were higher (71 and 5.8 ng g−1 ww shrimp)
than those found in the present study (Olsvik et al.
2019). Chronic exposure to low doses of tefluben-
zuron has also been shown to be toxic to both terres-
trial and aquatic insects, and to aquatic crustaceans
exposed via the water (Langford et al. 2011). For
example, the LC50 value for teflubenzuron following
a 28 d exposure was 220 ng g−1 soil dry weight (dw)
in Folsomia candida (collembola) (Campiche et al.
2006), while a 28 d exposure also resulted in signifi-
cant mortality amongst the aquatic midge Chorominus
riparius at concentrations ≥100 ng g−1 sediment dw
(Tassou & Schulz 2011). Furthermore, copepod (Tisbe
batta gliai) nauplii exposed to environmentally rele-
vant concentrations of teflubenzuron (0 to 320 ng l−1)
via the water for 7 d experienced significant mortality
(Macken et al. 2015), and the acute no-observed-
effect concentration (NOEC) and lowest-observed-
effect concentration (LOEC) were 3.2 ng l−1 and
10 ng l−1, respectively.
The accumulated levels of teflubenzuron in rock-
pool shrimp reported in this study (2 to 568.4 ng g−1
ww) are in line with levels reported earlier for wild
crustaceans living in the vicinity of medicated Nor-
wegian fish farms. For example, low levels of teflu -
benzuron (0.2−11.3 ng g−1 and 0.5−3.5 ng g−1 ww,
respectively) were detected in deepwater shrimp and
the amphipod Gammarus locusta collected 1−5 km
from farms located along the western and northern
Norwegian coastline within 1 mo of administration of
medication, while higher levels (43−185.7 ng g−1 ww)
were detected in brown crab Cancer pagurus
100−300 m from the farms (Langford et al. 2014). In
another study, teflubenzuron residues were exam-
ined in a range of crustacean species sampled within
300 m of a commercial fish farm along the west coast
of Norway (Samuelsen et al. 2015). During the period
of medication, the maximum concentrations of
teflubenzuron found were 319 ng g−1 ww in Norway
lobster Nephrops norvegicus, 393 ng g–1 ww in squat
lobster Munida sp., 865 ng g−1 ww in king crab Lith-
odes maja and 200 ng g−1 ww in deepwater shrimp
(Samuelsen et al. 2015). Lower, but still de tectable,
concentrations were found in many of the sampled
species 8 mo after the medication had been termi-
nated. The maximum concentrations measured in
shrimp, brown crab, squat lobster and Norway lob-
ster were 16.1, 20.6, 7.5 and 45.2 ng g−1 ww, respec-
tively (Samuelsen et al. 2015). The teflu benzuron lev-
els in shrimp from these studies are similar to, or
higher than, the LC50 values calculated in the present
study, highlighting that wild rockpool shrimp living
in the vicinity of fish farms using teflu benzuron are at
risk of exposure to potentially lethal concentrations
of the drug for long periods of time. It is also interest-
ing to note that chronic exposure to low doses of
teflubenzuron may cause sub-lethal effects in marine
crustaceans. Indeed, morphological deformities, such
as cracked walking legs and cloudy eyes, as well as
altered metabolomic re sponses associated with chitin
synthesis and energy metabolism, were observed in
pink shrimp exposed to sub-lethal doses of tefluben-
zuron (5.8−71 ng g–1 ww shrimp) for 46 d (Olsvik et
al. 2019). Furthermore, behavior, learning and activ-
ity of juvenile European lobster were altered follow-
ing a 113 d exposure to very low levels of tefluben-
zuron, with measured concentrations ~1 ng g–1 ww
lobster in exposed individuals (Cresci et al. 2018).
While mortality was the only toxicity endpoint meas-
ured in the present study, future work would be well
placed in assessing the sub-lethal effects of tefluben-
zuron exposure on shrimp and other deca pods, both
in laboratory and field-based settings.
Since teflubenzuron targets chitin synthesis and
induces mortality in connection with moulting, the
duration of this study was designed to include at least
one moult for every individual. Based on 70 indivi -
duals from the control group and the groups exposed
to the 3 lowest doses of teflubenzuron, the intermoult
period for rockpool shrimp at 13°C was 25.1 ± 5.7 d.
Exposure to low doses of teflubenzuron had no sig-
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nificant effect on the length of the intermoult period.
Comparing our results with those presented in Yaz-
dani et al. (2010), it is clear that water temperature is
an important regulator of the intermoult period,
which varied from 25.1 d at 13°C (this study) to less
than 9 d at 24°C (Yazdani et al. 2010).
Here we have shown that chronic exposure to envi-
ronmentally relevant concentrations of tefluben-
zuron was lethal to rockpool shrimp under laboratory
conditions. While it could be possible to extrapolate
our results to other crustacean species, sensitivities to
pesticides and other environmental pollutants can
differ widely even within taxonomic groups. There-
fore, further research into the toxicity of tefluben-
zuron on numerous non-target crustacean species is
desirable in order to facilitate robust environmental
risk assessments for this compound in the Norwegian
marine environment.
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